1. Mitral valve repair with a device for artificial chordal implantation at 2 yearsCentral MessagePerspective
- Author
-
Alberto Weber, MD, Maurizio Taramasso, MD, PhD, Andrej Podkopajev, MD, Vilius Janusauskas, MD, PhD, Diana Zakarkaite, MD, PhD, Rolf Vogel, MD, PhD, and Thierry Carrel, MD
- Subjects
chordal repair ,mitral valve repair ,mitral regurgitation ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 ,Surgery ,RD1-811 - Abstract
Objectives: This study examines the early and midterm safety, efficacy, and durability of mitral valve repair for primary mitral regurgitation (MR) using the ChordArt device (CoreMedic) for chordal replacement. Methods: Five patients with symptomatic severe primary degenerative MR due to isolated central posterior leaflet prolapse/flail were treated with the ChordArt device in a transseptal surgical approach and followed prospectively with periodical clinical and echocardiographic assessments for 2 years. Results: Reduction of MR immediately after the implantation of artificial chords was achieved in all patients showing no or trace MR (
- Published
- 2021
- Full Text
- View/download PDF